Evidence map›Paper›PMID 36841838›Full record

Trial reportScientific reports2023

On the potential of transauricular electrical stimulation to reduce visually induced motion sickness.

Emmanuel Molefi, Ian McLoughlin, Ramaswamy Palaniappan

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06782360 nacompletednot on this mapstarted 2025, after this paper: background citation

CAMSAN: Cognitive Augmentation Via Multimodal Sensing and Auricular Neurostimulation

TypeinterventionalSponsorOpenBCIRan2025 to 2026Enrolled45ConditionsHealthy, Cognitive Change, Effects of External Neurostimulation on CognitionArmsActive Neurostimulation, Sham Stimulation
NCT06892340 narecruitingnot on this mapstarted 2025, after this paper: background citation

A Non-Invasive, Non-Sedating Device to Mitigate Motion Sickness and Spatial Disorientation

TypeinterventionalSponsor59th Medical WingRan2025 to 2025Enrolled36ConditionsMotion SicknessArmsTranscutaneous Auricular Neurostimulation device
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Emmanuel MolefiSchool of Computing, University of Kent, Canterbury, UK. em576@kent.ac.uk.
Ian McLoughlinICT Cluster, Singapore Institute of Technology, Singapore, Singapore.
Ramaswamy PalaniappanSchool of Computing, University of Kent, Canterbury, UK.
University of Kent · GBSingapore Institute of Technology · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Perturbations in the autonomic nervous system occur in individuals experiencing increasing levels of motion sickness. Here, we investigated the effects of transauricular electrical stimulation (tES) on autonomic function during visually induced motion sickness, through the analysis of spectral and time-frequency heart rate variability. To determine the efficacy of tES, we compared sham and tES conditions in a randomized, within-subjects, cross-over design in 14 healthy participants. We found that tES reduced motion sickness symptoms by significantly increasing normalized high-frequency (HF) power and decreasing both normalized low-frequency (LF) power and the power ratio of LF and HF components (LF/HF ratio). Furthermore, behavioral data recorded using the motion sickness assessment questionnaire (MSAQ) showed significant differences in decreased symptoms during tES compared to sham condition for the total MSAQ scores and, central and sopite categories of the MSAQ. Our preliminary findings suggest that by administering tES, parasympathetic modulation is increased, and autonomic imbalance induced by motion sickness is restored. This study provides first evidence that tES may have potential as a non-pharmacological neuromodulation tool to keep motion sickness at bay. Thus, these findings may have implications towards protecting people from becoming motion sick and possible accelerated recovery from the malady.

Indexed as

Autonomic Nervous System DiseasesMotion SicknessAutonomic Nervous SystemCross-Over StudiesElectric StimulationHealthy VolunteersHeart RateHumans

Identifiers

PMID36841838
PMCPMC9968344
OpenAlexW4321850649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.